Peter W Mason

This inventor holds 35 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Antibody Therapeutics. Top assignees: Regeneron Pharmaceuticals, Inc., Seqirus UK Limited, Novartis Ag. Active years: 2012-2024.

USPTO Granted Patents = 35 (Patent Applications = 10)

% Patents Active = 97.1

CIPO Patents = 3 (Patent Applications = 10)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 130(Granted Patents)

Location History:

Sommerville, MA (US) (2014 - 2015)
Galveston, TX (US) (2012 - 2016)
Somerville, NY (US) (2020)
New York, NY (US) (2017 - 2021)
Somerville, MA (US) (2014 - 2023)
Cambridge, MA (US) (2017 - 2024)

Company Filing History:

12 out of 1,477

Regeneron Pharmaceuticals, Inc.

The University of Texas System

patents

5. 4 out of 79

Synthetic Genomics, Inc.

patents

6. 2 out of 545

Glaxosmithkline Biologicals Sa

patents

7. 2 out of 1,622

Lawrence Livermore National Security, LLC

patents

8. 1 out of 1

Synthetic Genomics Vaccines, Inc.

patent

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

Areas of Expertise:

Ebola Virus

Zika Virus

Human Antibodies

Antigen Delivery

Flavivirus Replicons

Influenza Virus

Reverse Genetics

Immunostimulatory Nanoparticles

Bispecific Antibodies

Nanolipoprotein Particles

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12152067 - Human antibodies to ebola virus glycoprotein (2024-11-26),

2. 11897918 - Compositions and methods to increase production (2024-02-13),

3. 11639370 - Antigen delivery platforms (2023-05-02),

4. 11571482 - Human antibodies toHemolysin A toxin (2023-02-07),

5. 11530255 - Human antibodies to Ebola virus glycoprotein (2022-12-20),

6. 11117955 - Anti-Zika virus antibodies and methods of use (2021-09-14),

7. 11078237 - Antigen delivery platforms (2021-08-03),

8. 10973899 - Flavivirus replicons (2021-04-13),

9. 10940211 - Human antibodies tohemolysin A toxin (2021-03-09),

10. 10865236 - Bispecific antigen-binding molecules that bind atarget antigen and a complement component and uses thereof (2020-12-15),

11. 10864264 - Influenza virus reassortment (2020-12-15),

12. 10829544 - Human antibodies to Ebola virus glycoprotein (2020-11-10),

13. 10610584 - Reverse genetics systems (2020-04-07),

14. 10501526 - Human antibodies to Ebola virus glycoprotein (2019-12-10),

15. 10500266 - Influenza virus reassortment (2019-12-10),

Title: The Inventor Peter W Mason

Introduction: Peter W Mason is a renowned inventor based in New York, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Peter W Mason holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, Peter W Mason has established himself as a leading figure in the world of inventions. His ability to think outside the box and create solutions to complex problems has earned him recognition globally.

Collaborations: Throughout his career, Peter W Mason has collaborated with top research institutions, universities, and companies to bring his inventions to life. His collaborative spirit has led to the development of cutting-edge technologies that have impacted numerous industries.

Conclusion: Peter W Mason's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and shape the future of technology.